Coates A, Fair H, Lea E, Doherty K
Int J Equity Health. 2025; 24(1):52.
PMID: 39994664
PMC: 11853287.
DOI: 10.1186/s12939-025-02386-6.
Andreoletti M, Blasimme A
Front Dement. 2025; 3():1463837.
PMID: 39830987
PMC: 11738615.
DOI: 10.3389/frdem.2024.1463837.
Siette J, Dodds L, Deckers K, Kohler S, Heger I, Strutt P
J Prev Alzheimers Dis. 2024; 11(5):1500-1512.
PMID: 39350397
PMC: 11436435.
DOI: 10.14283/jpad.2024.104.
Daly T
Cereb Circ Cogn Behav. 2024; 6:100193.
PMID: 39071741
PMC: 11273093.
DOI: 10.1016/j.cccb.2023.100193.
Shaaban C
Cereb Circ Cogn Behav. 2024; 6:100221.
PMID: 39071737
PMC: 11273090.
DOI: 10.1016/j.cccb.2024.100221.
Temporal trends in population attributable fractions of modifiable risk factors for dementia: a time-series study of the English Longitudinal Study of Ageing (2004-2019).
Chen S, Underwood B, Cardinal R, Chen X, Chen S, Amin J
BMC Med. 2024; 22(1):268.
PMID: 38926751
PMC: 11210022.
DOI: 10.1186/s12916-024-03464-2.
Socio-Cognitive Determinants of Lifestyle Behavior in the Context of Dementia Risk Reduction: A Population-Based Study in the Netherlands.
Bruinsma J, Loukas V, Kassiotis T, Heger I, Rosenberg A, Visser L
J Alzheimers Dis. 2024; 99(3):941-952.
PMID: 38759007
PMC: 11191482.
DOI: 10.3233/JAD-231369.
Experimental laboratory models as tools for understanding modifiable dementia risk.
Sinclair D, Canty A, Ziebell J, Woodhouse A, Collins J, Perry S
Alzheimers Dement. 2024; 20(6):4260-4289.
PMID: 38687209
PMC: 11180874.
DOI: 10.1002/alz.13834.
Population-level interventions for the primary prevention of dementia: a complex evidence review.
Walsh S, Wallace L, Kuhn I, Mytton O, Lafortune L, Wills W
EClinicalMedicine. 2024; 70:102538.
PMID: 38495526
PMC: 10940136.
DOI: 10.1016/j.eclinm.2024.102538.
How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors.
Bransby L, Rosenich E, Maruff P, Lim Y
J Prev Alzheimers Dis. 2024; 11(1):22-37.
PMID: 38230714
PMC: 10995020.
DOI: 10.14283/jpad.2023.119.
Linking Cognitive Impairment with Amyloid-β Accumulation in Alzheimer's Disease: Insights from Behavioral Tests and FTIR Spectroscopy.
Gaber H, Aly E, Mohamed E, Elfoly M, Rabie M, Talaat M
J Alzheimers Dis Rep. 2023; 7(1):1187-1200.
PMID: 38025802
PMC: 10657722.
DOI: 10.3233/ADR-230051.
Public Perspectives on Lifestyle-Related Behavior Change for Dementia Risk Reduction: An Exploratory Qualitative Study in The Netherlands.
Bruinsma J, Heger I, Loukas V, Kassiotis T, Karanasiou G, Fotiadis D
J Alzheimers Dis. 2023; 95(4):1635-1642.
PMID: 37718799
PMC: 10578282.
DOI: 10.3233/JAD-230217.
Against healthism in dementia prevention: Sharing responsibility.
Daly T
Aging Med (Milton). 2023; 6(2):207-208.
PMID: 37287672
PMC: 10242245.
DOI: 10.1002/agm2.12252.
Cross-sectional survey of attitudes and beliefs towards dementia risk reduction among Australian older adults.
Siette J, Dodds L, Deckers K, Kohler S, Armitage C
BMC Public Health. 2023; 23(1):1021.
PMID: 37254125
PMC: 10227810.
DOI: 10.1186/s12889-023-15843-0.
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.
Weinberg M, Zafar A, Magdamo C, Chung S, Chou W, Nayan M
JAMA Netw Open. 2023; 6(5):e2314336.
PMID: 37204792
PMC: 10199345.
DOI: 10.1001/jamanetworkopen.2023.14336.
[Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center].
Zeyen P, Sannemann L, Bohr L, Escher C, Muller T, Ramirez A
Nervenarzt. 2023; 94(5):392-399.
PMID: 36881112
DOI: 10.1007/s00115-023-01451-1.
The role of social deprivation and depression in dementia risk: findings from the longitudinal survey of health, ageing and retirement in Europe.
Hofbauer L, Rodriguez F
Epidemiol Psychiatr Sci. 2023; 32:e10.
PMID: 36786038
PMC: 9971857.
DOI: 10.1017/S2045796023000033.
Tackling structural inequalities to reduce concussion-related dementia in sportspeople.
Gallo V, McElvenny D
Aging (Albany NY). 2022; 14(23):9386-9387.
PMID: 36495590
PMC: 9792209.
DOI: 10.18632/aging.204431.
Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework.
Godbee K, Guccione L, Palmer V, Gunn J, Lautenschlager N, Francis J
J Alzheimers Dis. 2022; 89(3):789-802.
PMID: 35938252
PMC: 9697048.
DOI: 10.3233/JAD-220382.
Upping the dose of dementia risk reduction.
Daly T
Alzheimers Dement. 2022; 18(9):1699.
PMID: 35527368
PMC: 9514310.
DOI: 10.1002/alz.12692.
